PRINCIPEN W Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Principen W, and what generic alternatives are available?
Principen W is a drug marketed by Apothecon and is included in two NDAs.
The generic ingredient in PRINCIPEN W is ampicillin/ampicillin trihydrate; probenecid. Additional details are available on the ampicillin/ampicillin trihydrate; probenecid profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRINCIPEN W?
- What are the global sales for PRINCIPEN W?
- What is Average Wholesale Price for PRINCIPEN W?
Summary for PRINCIPEN W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | PRINCIPEN W at DailyMed |
US Patents and Regulatory Information for PRINCIPEN W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | PRINCIPEN W/ PROBENECID | ampicillin/ampicillin trihydrate; probenecid | CAPSULE;ORAL | 062150-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | PRINCIPEN W/ PROBENECID | ampicillin/ampicillin trihydrate; probenecid | CAPSULE;ORAL | 050488-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
